NCT05934331 2025-09-12A LM-302 Combination With Other Anti-Tumor Therapies Phase ll StudyLaNova Medicines LimitedPhase 2 Recruiting276 enrolled
NCT06427005 2025-01-22Fruquintinib Plus S-1 and Raltitrexed (RSF) for MCRCWest China HospitalPhase 2 Recruiting66 enrolled